Cite
APA Citation
Harvey, R. D., Adams, V. R., Beardslee, T., & Medina, P. (2020). afatinib for the treatment of EGFR mutation-positive NSCLC: A review of clinical findings. Journal of oncology pharmacy practice, 26, 1461–1474. http://access.bl.uk/ark:/81055/vdc_100105423659.0x000063